<DOC>
	<DOCNO>NCT01833312</DOCNO>
	<brief_summary>The purpose study determine systemic cooling target temperature 34 35°C , start within 6 hour symptom onset maintain 12 hour , improve functional outcome 3 month patient acute ischaemic stroke .</brief_summary>
	<brief_title>Cooling Plus Best Medical Treatment Versus Best Medical Treatment Alone Acute Ischaemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<criteria>Written inform consent obtain patient his/her legally acceptable representative arrangement may legally establish participate country Patients sex age ≥18 year Estimated body weight 50 include 120kg Diagnosis acute ischaemic stroke Possibility start therapeutic hypothermia within 6 hour onset stroke Possibility start therapeutic hypothermia within 150 minute start alteplase administration patient receive thrombolysis trial site within 150 minute start endovascular treatment , later Possibility start therapeutic hypothermia within 150 minute admission trial site patient receive thrombolysis patient receive thrombolysis different site mRS score ≤2 prior onset stroke NIHSS score ≥6 GCS motor response subscale score ≥5 Use monoamineoxidase inhibitor 14 day prior screen Current use medication interact pethidine buspirone , i.e. , ritonavir , phenytoin , cimetidine , phenothiazine , opioids partial opioid agonist ( e.g. , pentazocine , nalbuphine , buprenorphine ) Acute alcohol intoxication Opioid addiction Nursing mother pregnant woman , verify positive urine pregnancy test female childbearing potential Known hypersensitivity IMPs formulation ingredient Patient imprison lawfully kept institution Employee direct relative employee CRO ( applicable ) , department investigator , sponsor Participation interventional clinical trial within last 4 week , exclusion period another trial Prior participation trial Any acutely lifethreatening condition acute ischaemic stroke Rapidly resolve stroke symptom Evidence CT MRI intracranial haemorrhage tumour encephalitis diagnosis likely cause present symptom acute ischaemic stroke . Haemorrhagic transformation infarct exclusion criterion , except parenchymal haematoma cover 30 % infarcted area , significant spaceoccupying effect , bleed remote infarcted area Known convulsive disorder , acute close angle glaucoma , myasthenia gravis SPO2 &lt; 94 % ( measure pulse oximetry ) nasal oxygen administration Other severe respiratory disorder Bradycardia ( &lt; 40 bpm ) Severe cardiac failure , define NYHA classification ≥III Myocardial infarction angina pectoris 3 month prior screen Vasospastic disorder ( e.g. , Raynaud 's disease ) Haematological dyscrasia ( e.g. , sickle cell disease , cryoglobulinaemia ) Known platelet count &lt; 100,000/mm3 Known INR &gt; 1.7 Skin damage ( e.g. , inflammation , burn , injury , ulceration , hive , rash ) sit intend used cooling Clinical diagnosis sepsis Known severe hepatic impairment ( serum ALAT and/or ASAT &gt; 3 time ULN ) Known renal impairment ( serum creatinine &gt; 2mg/100ml ) Addison 's disease Any condition may interfere , aggravate , therapeutic hypothermia Any condition think reduce compliance cooperate trial procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>acute ischemic stroke</keyword>
	<keyword>hypothermia</keyword>
</DOC>